2261 - 2270 of 6284 Results
Title
Year
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients2021OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 19
-
OPENTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 8
- Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scores2021OPENTitle: Exploratory analysis of the genetics of impulse control disorders in Parkinson's disease using genetic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 74End Page: 77Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.003Best OA location URL: https://hal.archives-ouvertes.fr/hal-03298502Citation Count: 8
-
OPENTitle: Investigating ELOVL7 coding variants in multiple system atrophyJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 749Issue #:Start Page: 135723End Page: 135723Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2021.135723Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7983070Citation Count: 2
- ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study2021OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 42
- Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications2021OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 49
-
OPENTitle: Diagnostic criteria for blepharospasm: A multicenter international studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 109End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9048224Citation Count: 30
- Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson disease2021OPENTitle: Diffusion along perivascular spaces reveals evidence supportive of glymphatic function impairment in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8429254Citation Count: 116
- Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease2021OPENTitle: Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 22End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9310432Citation Count: 8
-
OPENTitle: Attentional dysfunction and the punding spectrum in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 84Issue #:Start Page: 23End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7980283Citation Count: 10